Items where Author is "Szucs, T. D."

2021

Jeiziner, C. and Suter, K. and Wernli, U. and Barbarino, J. M. and Gong, L. and Whirl-Carrillo, M. and Klein, T. E. and Szucs, T. D. and Hersberger, K. E. and Meyer Zu Schwabedissen, H. E.. (2021) Pharmacogenetic information in Swiss drug labels - a systematic analysis. Pharmacogenomics Journal, 21 (4). pp. 423-434.

2014

Vulsteke, C. and Pfeil, A. M. and Schwenkglenks, M. and Pettengell, R. and Szucs, T. D. and Lambrechts, D. and Peeters, M. and van Dam, P. and Dieudonné, A. S. and Hatse, S. and Neven, P. and Paridaens, R. and Wildiers, H.. (2014) Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel. Breast cancer research and treatment, Vol. 147, H. 3. pp. 557-570.

2012

Moch, H. and Blank, P. R. and Dietel, M. and Elmberger, G. and Kerr, K. M. and Palacios, J. and Penault-Llorca, F. and Rossi, G. and Szucs, T. D.. (2012) Personalized cancer medicine and the future of pathology. Virchows Archiv, Vol. 460. pp. 3-8.

2011

Szucs, T. D. and Blank, P. R. and Schwenkglenks, M. and Aapro, M.. (2011) Potential health economic impact of intravenous iron supplementation to erythropoiesis-stimulating agent treatment in patients with cancer- or chemotherapy-induced anemia. Oncology, 81 (1). pp. 45-49.

2010

Matter-Walstra, K. W. and Dedes, K. J. and Schwenkglenks, M. and Brauchli, P. and Szucs, T. D. and Pestalozzi, B. C.. (2010) Trastuzumab beyond progression: a cost-utility analysis. Annals of Oncology, 21 (11). pp. 2161-2168.

2009

Blank, P. R. and Schwenkglenks, M. and Szucs, T. D.. (2009) Disparities in influenza vaccination coverage rates by target group in five European countries : trends over seven consecutive seasons. Infection, 37. pp. 390-400.